ADAR1 Capital Management’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
Other funds holding CUE
ADAR1 Capital Management's CUE Position: Q3 2026 in Review
ADAR1 Capital Management reduced its Cue Biopharma (CUE) stake by 20% in Q3 2026, selling an estimated $334K and leaving 43,935 shares worth $1.14M. The position accounts for 0.05% of the portfolio, ranked #173.
ADAR1 Capital Management first reported a position in CUE in Q2 2026 and has held it in 2 quarters since. The position peaked at $1.74M in Q2 2026. 58 funds tracked by Wall St. Rank hold CUE as of Q3 2026.
- ADAR1 Capital Management held 43,935 shares of Cue Biopharma worth $1.14M as of Q3 2026.
- ADAR1 Capital Management sold 11,258 Cue Biopharma shares in Q3 2026, an estimated $334K.
- Cue Biopharma made up 0.05% of ADAR1 Capital Management's portfolio in Q3 2026, its #173 holding.
- ADAR1 Capital Management first reported a position in Cue Biopharma in Q2 2026 and has held it in 2 quarters since.
- ADAR1 Capital Management's Cue Biopharma position peaked at $1.74M in Q2 2026.
- 58 funds tracked by Wall St. Rank held Cue Biopharma as of Q3 2026.
Based on ADAR1 Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.